Interaction Guide · Research summary

Can I take Hypericum Perforatum with Citalopram?

Review Hypericum Perforatum with Citalopram: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Citalopram labeling specifically warns about St John’s wort and serotonin syndrome. Review any intended use with the prescriber.

What this answer covers

Oral Hypericum perforatum with citalopram hydrobromide tablets.

Supplement or preparation
Hypericum perforatum
Medication ingredient
citalopram

The warning names this herb

The citalopram label includes St John’s wort among serotonergic products that can increase serotonin-syndrome risk.

Natural origin does not remove the warning

Tell the prescriber about the extract, dose and all mood products. The label warning does not establish that every extract produces the same exposure.

Review starting and stopping

Do not add the herb or change citalopram to manage the combination yourself. A gap between doses is not established protection.

Recognize concerning symptoms

Seek urgent medical care for a combination of agitation or confusion, fever or heavy sweating, tremor, muscle rigidity or repeated twitching. These can be signs of serotonin syndrome; a single nonspecific symptom does not establish the diagnosis.

Evidence and practical considerations

Side effects & toxicity

Exact-label serotonergic precaution supports individual review.

Exact scope
Oral Hypericum perforatum with citalopram hydrobromide tablets. with Exact oral citalopram hydrobromide film-coated tablets. RxNorm IN2556 / PIN221078 hydrobromide tablets. Racemic citalopram is distinct from escitalopram.
Medication form and route
oral
Timing or duration
Source-specific single-dose, repeated-dose and observational exposures distinguished.

What remains uncertain

  • No exact-pair incidence or universally safe herb dose or spacing established.

Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.

Research conclusion: supported with conditions · Evidence assessment: low

Read the supporting source summaries

Source 1: current product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral citalopram.

Label names tryptophan and St John’s wort in serotonin warnings; dose-dependent QT and electrolyte precautions are distinct from sedation and nutritional augmentation.

How this applies: RxNorm IN2556 / PIN221078 hydrobromide tablets. Racemic citalopram is distinct from escitalopram.

No universal supplement interval, event rate or preparation equivalence established.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Current exact available claims adjudicated using original captures and explicit identity and comparator limits.
Research summary published

Article revision: 0d91d51a4c9fe7f1

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.